Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- PMID: 28098591
- DOI: 10.1097/CCM.0000000000002255
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Abstract
Objective: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012."
Design: A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development.
Methods: The panel consisted of five sections: hemodynamics, infection, adjunctive therapies, metabolic, and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable.
Results: The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions.
Conclusions: Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.
Comment in
-
Best practice statements and recommendations for caring for critically ill patients with COVID-19.Ann Intern Med. 2020 Jun 16;172(12):JC62. doi: 10.7326/ACPJ202006160-062. Ann Intern Med. 2020. PMID: 32539521
Similar articles
-
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.Intensive Care Med. 2017 Mar;43(3):304-377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18. Intensive Care Med. 2017. PMID: 28101605
-
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children.Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106. doi: 10.1097/PCC.0000000000002198. Pediatr Crit Care Med. 2020. PMID: 32032273
-
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941
-
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.Intensive Care Med. 2013 Feb;39(2):165-228. doi: 10.1007/s00134-012-2769-8. Epub 2013 Jan 30. Intensive Care Med. 2013. PMID: 23361625 Free PMC article.
-
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.Intensive Care Med. 2020 Feb;46(Suppl 1):10-67. doi: 10.1007/s00134-019-05878-6. Intensive Care Med. 2020. PMID: 32030529 Free PMC article.
Cited by
-
Reevaluating vitamin C in sepsis and septic shock: a potential benefit in severe cases?Front Med (Lausanne). 2024 Oct 29;11:1476242. doi: 10.3389/fmed.2024.1476242. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39540046 Free PMC article. Review.
-
Small volume fluid resuscitation and supplementation with 20% albumin versus buffered crystalloids in adults with septic shock: A protocol for a randomised feasibility trial.J Intensive Care Soc. 2024 Oct 18;25(4):419-426. doi: 10.1177/17511437241292194. eCollection 2024 Nov. J Intensive Care Soc. 2024. PMID: 39524074 Free PMC article.
-
Timely empirical antibiotic therapy against sepsis in a rural Norwegian ambulance service: a prospective cohort study.BMC Health Serv Res. 2024 Oct 31;24(1):1320. doi: 10.1186/s12913-024-11827-x. BMC Health Serv Res. 2024. PMID: 39478504 Free PMC article.
-
Dyschloremia and Renal Outcomes in Critically Ill Patients With Sepsis: A Prospective Cohort Study: Dyschloremia and Renal Outcomes in Sepsis.Crit Care Res Pract. 2024 Oct 1;2024:8848405. doi: 10.1155/2024/8848405. eCollection 2024. Crit Care Res Pract. 2024. PMID: 39473920 Free PMC article.
-
The Relationship Between Soluble Interleukin-17 Receptor Levels and CD3-Positive T Cells and Lymphocytes in Patients with Sepsis and Their Predictive Clinical Significance.J Inflamm Res. 2024 Oct 21;17:7543-7550. doi: 10.2147/JIR.S479310. eCollection 2024. J Inflamm Res. 2024. PMID: 39464344 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
